Picture of Femasys logo

FEMY Femasys News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Femasys Inc expected to post a loss of 14 cents a share - Earnings Preview

Femasys Inc FEMY.OQ FEMY.O is expected to  show a rise in quarterly revenue when it reports  results on August 11 (estimated) for the period ending September 30 2025

The Suwanee Georgia-based  company is expected to report a 276.6% increase in revenue to $2.09 million from $555 thousand a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Femasys Inc is for a loss of 14 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had fallen by about 5.9% in the last three months. ​

Wall Street's median 12-month price target for Femasys Inc is $7.00, about 87.2% above its last closing price of $0.89

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Jun. 30 2025-0.18-0.18-0.15Beat16.7
Mar. 31 2025-0.19-0.19-0.23Missed-21.1
Dec. 31 2024-0.25-0.18-0.23Missed-24.3​
Sep. 30 2024-0.20-0.20-0.24Missed-20
​​Jun. 30 2024-0.17-0.17-0.21Missed-21.2
Mar. 31 2024-0.19-0.19-0.17Beat10.5​
Dec. 31 2023-0.21-0.21-0.19Beat10.6
Sep. 30 2023-0.23-0.22-0.26Missed-15.6
This summary was machine generated August 9 at 00:13 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Femasys

See all news